Rima Nabbout Selected Research

Epileptic Syndromes

1/2021	Pharmacotherapy for Seizures in Tuberous Sclerosis Complex.
1/2020	Transition of patients with childhood onset epilepsy: Perspectives from pediatric and adult neurologists.
12/2019	SCN1A-related phenotypes: Epilepsy and beyond.
1/2016	ADHD in childhood epilepsy: Clinical determinants of severity and of the response to methylphenidate.
11/2014	Current role of rufinamide in the treatment of childhood epilepsy: literature review and treatment guidelines.
8/2013	Use of dietary therapy for status epilepticus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rima Nabbout Research Topics

Disease

61	Epilepsy (Aura) 04/2024 - 04/2004
49	Seizures (Absence Seizure) 03/2024 - 10/2006
40	Tuberous Sclerosis (Bourneville's Disease) 11/2023 - 11/2012
29	Myoclonic Epilepsies (Myoclonic Encephalopathy) 04/2024 - 07/2004
13	Brain Diseases (Brain Disorder) 03/2024 - 06/2008
8	Inborn Genetic Diseases (Disease, Hereditary) 07/2022 - 11/2014
8	Infantile Spasms (West Syndrome) 01/2021 - 01/2009
7	Status Epilepticus (Complex Partial Status Epilepticus) 12/2023 - 10/2010
7	Intellectual Disability (Idiocy) 07/2022 - 01/2016
7	Drug Resistant Epilepsy 03/2022 - 03/2008
6	Rare Diseases (Rare Disease) 10/2023 - 03/2013
6	Fever (Fevers) 10/2023 - 10/2010
6	Epileptic Syndromes 01/2021 - 08/2013
6	Astrocytoma (Pilocytic Astrocytoma) 01/2019 - 07/2013
5	Spasm (Spasms) 04/2024 - 01/2021
5	Lennox Gastaut Syndrome 08/2023 - 11/2014
5	Angiomyolipoma 01/2020 - 04/2016
4	Autism Spectrum Disorder 07/2022 - 06/2019
3	Sleepiness 12/2023 - 01/2017
3	Channelopathies 01/2021 - 01/2013
3	Idiopathic Generalized Epilepsy 10/2013 - 10/2006
3	Absence Epilepsy (Childhood Absence Epilepsy) 12/2009 - 10/2006
2	Partial Epilepsies (Epilepsy, Partial) 01/2022 - 04/2009
2	Cognitive Dysfunction 01/2022 - 01/2020
2	Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy) 01/2021 - 01/2021
2	Pyridoxine-dependent epilepsy 01/2021 - 07/2010
2	Diarrhea 01/2020 - 01/2017
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2020 - 01/2016
2	Autistic Disorder (Autism) 01/2020 - 06/2019
2	Fatigue 01/2020 - 01/2017
2	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2019 - 01/2017
2	Generalized Epilepsy with Febrile Seizures Plus 01/2019 - 07/2009
2	Infections 04/2014 - 09/2012
2	Encephalitis (Encephalitis, Rasmussen) 08/2013 - 09/2012
2	Inflammation (Inflammations) 09/2012 - 01/2011
1	CDKL5 deficiency disorder 03/2024
1	Metabolic Diseases (Metabolic Disease) 01/2023
1	Sudden Unexpected Death in Epilepsy 01/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2023
1	Neurodevelopmental Disorders 10/2022
1	Neurologic Manifestations (Neurological Manifestations) 01/2021
1	Neoplasms (Cancer) 01/2021
1	Pyridoxamine 5-Prime-Phosphate Oxidase Deficiency 01/2021
1	Disease Progression 01/2021
1	Autoimmune Diseases of the Nervous System 01/2021
1	COVID-19 11/2020

Drug/Important Bio-Agent (IBA)

40	trans-sodium crocetinate (crocetin)IBA 11/2023 - 11/2012
25	Anticonvulsants (Antiepileptic Drugs)IBA 04/2024 - 04/2004
16	Vigabatrin FDA Link 04/2024 - 01/2009
13	CannabidiolIBA 04/2024 - 01/2017
10	stiripentolIBA 12/2023 - 07/2011
10	Everolimus FDA Link 11/2023 - 04/2016
9	FenfluramineIBA 10/2023 - 01/2019
6	SteroidsIBA 10/2023 - 03/2008
5	Biomarkers (Surrogate Marker)IBA 11/2023 - 06/2019
4	Clobazam (HR 376)IBA 08/2023 - 01/2016
4	Sodium Channels (Sodium Channel)IBA 01/2022 - 07/2009
3	SolutionsIBA 10/2023 - 01/2017
3	gamma-Aminobutyric Acid (GABA)IBA 01/2021 - 01/2019
3	Ion Channels (Ion Channel)IBA 01/2021 - 04/2004
3	TOR Serine-Threonine KinasesIBA 01/2021 - 10/2016
3	Immunoglobulin E (IgE)IBA 12/2009 - 10/2006
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 03/2024 - 06/2008
2	Blood Glucose (Blood Sugar)IBA 10/2023 - 02/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 07/2010
2	Aminobutyrates (Aminobutyric Acid)IBA 10/2022 - 03/2019
2	Pyridoxine (Pyridoxin)FDA LinkGeneric 01/2021 - 07/2010
2	Valproic Acid (Depakote)FDA LinkGeneric 01/2019 - 01/2016
2	MTOR InhibitorsIBA 01/2019 - 04/2016
2	EnzymesIBA 01/2019 - 07/2010
2	N-Methylaspartate (NMDA)IBA 01/2019 - 09/2012
2	SodiumIBA 01/2016 - 09/2015
2	Chloride Channels (Chloride Channel)IBA 03/2009 - 07/2007
2	Voltage-Gated Sodium ChannelsIBA 04/2006 - 07/2004
1	SandIBA 11/2023
1	Mitochondrial DNA (mtDNA)IBA 01/2023
1	GABA-A Receptors (GABA(A) Receptor)IBA 10/2022
1	MicroRNAs (MicroRNA)IBA 07/2022
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2022
1	CytokinesIBA 01/2022
1	Adenosine Triphosphatases (ATPase)IBA 01/2022
1	Red DND-99IBA 01/2022
1	Pyridoxal Phosphate (Pyridoxal 5 Phosphate)IBA 01/2021
1	Phosphates (Orthophosphate)IBA 01/2021
1	VitaminsIBA 01/2021
1	Oxidoreductases (Dehydrogenase)IBA 01/2021
1	Explosive Agents (Explosives)IBA 01/2021
1	Shaw Potassium ChannelsIBA 01/2021
1	Carbapenems (Carbapenem Antibiotics)IBA 04/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2020
1	beta-LactamsIBA 04/2020

Therapy/Procedure

32	Therapeutics 04/2024 - 01/2009
9	Ketogenic Diet 01/2023 - 04/2009
3	Transition to Adult Care 01/2020 - 01/2017
2	Off-Label Use 01/2018 - 03/2013
1	Genomic Medicine 03/2022
1	Drug Therapy (Chemotherapy) 01/2021
1	Treatment Delay 01/2021
1	Precision Medicine 12/2020
1	Ambulatory Care (Outpatient Care) 11/2020